Drug-induced lupus;Lupus inducido por fármacos

Medicina Clinica

Volumn 135, Issue 3, 2010, Pages 124-129

  Zamorano, Ma Angeles Aguirre ^a   Pedrera, Rosario López ^a   Lozano, Ma Jose Cuadrado ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anti TNFalfa; Autoimmunity; Minocycline; Statins

Indexed keywords

ACEBUTOLOL; ADALIMUMAB; ALLOPURINOL; AMINOGLUTETHIMIDE; ATENOLOL; ATORVASTATIN; BENOXAPROFEN; CAPTOPRIL; CARBAMAZEPINE; CHLORPROMAZINE; CHLORPROTHIXENE; CHLORTALIDONE; CIMETIDINE; CLONIDINE; DANAZOL; DICLOFENAC; ENALAPRIL; ETANERCEPT; HYDRALAZINE; ISONIAZID; METHYLDOPA; MEVINOLIN; MINOCYCLINE; MINOXIDIL; NALIDIXIC ACID; PROCAINAMIDE; QUINIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG;

AGE DISTRIBUTION; ANTIBODY DETECTION; ARTHRALGIA; ARTHRITIS; CLINICAL FEATURE; FEVER; HUMAN; IMMUNOLOGICAL TOLERANCE; LUPUS LIKE SYNDROME; LYMPHOCYTE ACTIVATION; MYALGIA; REVIEW; RISK FACTOR; SEX DIFFERENCE; VASCULITIS; WEIGHT REDUCTION; CHEMICALLY INDUCED; LUPUS ERYTHEMATOSUS, SYSTEMIC;

HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77953232432     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.04.035     Document Type: Review

References (42)

1. B.J. Hoffman Sensitivity of sulfadiazine resembling acute disseminated lupus erythematosus Arch Dermatol Syph 51 1945 190 192
2. J.D. Morrow, H.A. Schroeder, and H.M. Perry Jr Studies on the control of hypertension by Hyphex. II. Toxic reactions and side effects Circulation 8 1953 829 839
3. A.T. Ladd Procainamide-induced lupus erythematosus N Engl J Med 267 1962 1357 1358
4. R.L. Rubin Drug-induced lupus Toxicology 209 2005 135 147
5. J. Uetrecht Current trends in drug-induced autoimmunity Autoimmun Rev 4 2005 309 314
6. A.T. Borchers, C.L. Keen, and M.E. Gershwin Drug-induced Lupus Ann N Y Acad Sci 1108 2007 166 182
7. A.B. Mongey, R. Donovan-Brand, T.J. Thomas, L.E. Adams, and E.V. Hess Serologic evaluation of patients receiving procainamide Arthritis Rheum 35 1992 1108 1109
8. J.A. Alloway, and M.P. Salata Quinidine-induced rheumatic disorders Semin Arthritis Rheum 24 1995 315 322
9. M. De Bandt, J. Sibilia, X. Le Loet, S. Prouceau, B. Fautrel, and C. Marcelli Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey Arthritis Res Ther 7 2005 R545 R551
10. B. Haraoui, and E. Keystone Musculoskeletal manifestations and autoimmune diseases related to new biologic agents Curr Opin Rheumatol 18 2006 96 100
11. R.L. Rubin Drug-induced lupus toxicology 209 2005 135 147
12. I. Gunnarsson, L. Kanerud, E. Pettersson, I. Lundberg, S. Lindblad, and B. Ringertz Predisposing factors in sulphasalazine-induced systemic lupus erythematosus Br J Rheumatol 36 1997 1089 1094
13. G.V. Prasad, S. Bastacky, and J.P. Johnson Propylthiouracil-induced diffuse proliferative lupus nephritis: Review of immunological complications J Am Soc Nephrol 8 1997 1205 1210
14. M.B. Stokes, K. Foster, G.S. Markowitz, F. Ebrahimi, W. Hines, and D. Kaufman Development of glomerulonephritis during ant-TNF-alpha therapy for rheumatoid arthritis Nephrol Dial Transplant 20 2005 1400 1406
15. S. Donnelly, D.A. Levinson, and D.V. Doyle Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy Br J Rheumatol 32 1993 251 253
16. M. Srivastava, A. Rencic, G. Diglio, H. Santana, P. Bonitz, and R. Watson Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus Arch Dermatol 139 2003 45 49
17. R.W. Burlingame The clinical utility of antihistone antibodies. Autoantibodies reactive with cromatin in systemic lupus erythematosus and drug-induced lupus Clin Lab Med 17 1997 367 378
18. R.L. Rubin, S.A. Bell, and R.W. Burlingame Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complexe J Clin Invest 90 1992 165 173
19. M.C. Sturkenboom, C.R. Meier, H. Jick, and B.H. Stricker Minocycline and lupuslike syndrome in acne patients Arch Inter Med 159 1999 493 497
20. D.J. Margolis, O. Hoffstad, and W. Bilker Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus British Journal Dermatology 157 2007 540 546
21. J.G. Erdozain, M.J. Cuadrado, G.R.V. Hughes, and M.A. Khamashta Autoimmune manifestations induced by minocycline: Differences with classic drug-induced lupus Arthritis Rheum 54 2006 S149
22. B. Noel Lupus erythematosus and other autoinmune diseases related to statin therapy: A systematic review J Eur Acad Dermatol Venereol 21 2007 17 24
23. S. Ahmad Lovastatin-induced lupus erythematosus Arch Inter Med 151 1991 1667 1668
24. B. Bannwarth, G. Miremont, and P.M. Papapietro Lupus-like syndrome associated with simvastatin Arch Inter. Med 152 1992 1093
25. J. Hanson, and D. Bossingham Lupus-like syndrome associated with simvastatin Lancet 352 1998 1070
26. L. Rudski, M.A. Rabinovitch, and D. Danoff Systemic inmune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature Medicine (Baltimore) 77 1998 378 383
27. R. Khosla, A.N. Butman, and D.F. Hammer Simvastatin-induced lupus erythematosus South Med J 91 1998 83 84
28. M.K. Sridhar, and A. Abdulla Fatal lupus-like síndrome and ARDS induced by fluvastatin Lancet 352 1998 114
29. A. Ahmad, M.T. Letcher, and T.M. Roy Simvastatin-induced lupus-like syndrome Tenn Med 93 2000 21 22
30. J. Jiménez-Alonso, L. Jaimez, J.M. Sabio, C. Hidalgo, and L. León Atorvastatin-induced reversible positive antinuclear antibodies Am J Med 112 2002 329 330
31. I.W. Graziadei, G.E. Obermoser, N.T. Sepp, K.H. Erhart, and W. Vogel Drug-induced lupus-like síndrome associated with severe autoinmune hepatitis Lupus 12 2003 409 412
32. R.N. Maini, E.W. St Clair, F.C. Breedveld, D. Furst, J. Kalden, and M. Weisman Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomise phase III trial. ATTRACT Study Group Lancet 354 1999 1932 1939
33. A. Markham, and H.M. Lamb Infliximab: A review of its use in the management of rheumatoid arthritis Drugs 59 2000 1341 1359
34. S. Vermeire, M. Noman, G. Van Assche, F. Baert, K. Steen, and N. Esters Autoinmunity associated with anti-tumor necrosis factor alpha treatment in Crohn′s disease: A prospective cohort study Gastroenterology 125 2003 32 39
35. P.J. Charles, R.J. Smeenk, J. De Jong, M. Feldmann, and R.N. Maini Assesment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with Infliximab, a monoclonal antibody to tumor necrosis factor α Arthritis Rheum 11 2000 2383 2390
36. M. Benucci, F. Gobbi, F. Fossi, M. Manfredi, and A. Del Rosso Drug-induced lupus after treatment with infliximab in rheumatoid arthritis J Clin Rheumatol 11 2005 47 49
37. M. De Bandt, J. Sibilia, X. Le Loet, S. Prouzeau, Fautrel, and C. Marcelli Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey Arthritis Res Ther 7 2005 R545 R551
38. M.A. Descalzo Comité científico de BIOBADASER y Grupo de estudio BIOBADASER Registro español de acontecimientos adversos de terapias biológicas en enfermedades reumáticas (BIOBADASER): informe de la situación, 26 de enero de 2006 Reumatol Clin 3 2007 4 20
39. M. Ramos-Casals, P. Brito-Zerón, S. Muñoz, M. Soria, D. Galiana, and L. Bertolaccini Autoimmune diseases induced by TNF-targeted therapies. Analysis of 233 cases Medicine 86 2007 242 251
40. A.P. Cairns, M.K. Duncan, A.E. Hinder, and A.J. Taggart New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis Ann Rheum Dis 61 2002 1031 1032
41. E. Favalli, L. Sinigaglia, M. Varenna, and C. Arnoldi Drug-induced lupus following treatment with infliximab in rheumatoid arthritis Lupus 11 2002 753 755
42. C. Eriksson, S. Engstrand, K.G. Sundqvist, and S. Rantapää- Dahlqvist Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha Ann Rheum Dis 64 2005 403 407